Scientific Approach
Lophius’ technologies enable the pathogen-specific stimulation of a broad spectrum of clinically-relevant effector cells and the identification of markers secreted by these cells facilitating the development of novel molecular diagnostic solutions.
Learn more
Lophius in TB
Our core program addresses an unmet clinical need in tuberculosis (TB), an often underestimated global epidemic. TB remains one of the 10 leading causes of death worldwide with around 1.5 million casualties each year.
Learn more
T-Track® CMV
Lophius in CMV
We have successfully developed and are already commercializing our clinically-validated CE-marked diagnostic kit
T-Track® CMV to individualize transplant patient management by allowing personalized CMV disease risk stratification.
Loading...
No Records Found
Sorry, no records were found. Please adjust your search criteria and try again.
We use cookies to personalize content and ads, to provide social media features and to analyze our website traffic. We also share information about your use of our website with our social media, advertising, and analytics partners. Read more about how we use cookies by clicking on 'Privacy Policy'. Click the "I agree" button to continue to use this site.I agreePrivacy Policy
